Ambiq Micro, Inc. (AMBQ) — Current Report

AI-Powered SEC Filing Analysis

Latest Current Report Filed: 2026-01-21

Key Insights

Ambiq Micro's preliminary financial results for 2025 indicate strong revenue growth, with net sales expected to range between $71.77 million and $72.47 million, driven by strong sales outside of Mainland China.
The company's gross margin is anticipated to be between 43.7% and 44.6%, with non-GAAP gross margin expected to be even higher, suggesting operational efficiency and profitability.
Ambiq Micro's presence outside of Mainland China has increased, with net sales outside of Mainland China expected to account for 91.0% to 91.6% of total net sales, indicating geographical diversification and potential reduced reliance on the Chinese market.

Want the newest filings?

This analysis covers the filing from 2026-01-21. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Current Report filings

Filed: 2026-01-08

Ambiq Micro, Inc. has expanded its board of directors from six to seven members with the appointment of Dr. Bernard B. Banks, an experienced leader with a strong background in organizational psychology and leadership development.
Dr. Banks will serve as a Class III director until the company's 2028 annual meeting, and has also been appointed to the Audit Committee of the board.
The appointment of Dr. Banks suggests Ambiq Micro is focused on enhancing its governance and leadership capabilities as it continues to grow as an emerging public company.

Other reports for Ambiq Micro, Inc.

Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.